Enter assignee name

% Expired Patents = 53.8

Forward Citations = 352

Loading Chart...

5 inventors (with patents filed for the assignee):

Barbara P Wallner (13 out of 34 patents)

Glenn T Miller (7 out of 11 patents)

Sharlene Adams (3 out of 13 patents)

4. Barry Jones (3 out of 3 patents)

5. William Bachovchin (3 out of 3 patents)

13 patents: Sort by Forward Citations

1. 7282484 - Anti-tumor agents (2007-10-16),

2. 7276371 - Stimulation of hematopoietic cells in vitro (2007-10-02),

3. 7265118 - Regulation of substrate activity (2007-09-04),

4. 7259138 - Anti-tumor agents (2007-08-21),

5. 7067489 - Hematopoietic stimulation (2006-06-27),

6. 6979697 - Regulation of substrate activity (2005-12-27),

7. 6949514 - Anti-tumor agents (2005-09-27),

8. 6890904 - Anti-tumor agents (2005-05-10),

9. 6770628 - Hematopoietic stimulation (2004-08-03),

10. 6703238 - Methods for expanding antigen-specific T cells (2004-03-09),

11. 6355614 - Cyclic boroproline compounds (2002-03-12),

12. 6300314 - Hematopoietic stimulation (2001-10-09),

13. 6258597 - Stimulation of hematopoietic cells in vitro (2001-07-10),

Point Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of oncology drugs. With a focus on targeted therapies for solid tumors, the company aims to improve outcomes for cancer patients. Point Therapeutics has a strong portfolio of novel drug candidates in various stages of development, backed by a team of experienced researchers and clinicians.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

13 Patents

#157 in Boston, MA

#1,441 in Massachusetts

#23,794 in US

#44,921 in the World

Boston, MA, United States of America

Point Therapeutics, Inc.